Record title

Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights

Record identifier

TN_cdi_pubmed_primary_32781872

https://collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_32781872

Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights

About this item

Full title

Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights

Publisher

England: Taylor & Francis

Journal title

Journal of enzyme inhibition and medicinal chemistry, 2020, Vol.35 (1), p.1616-1630

Record Identifier

TN_cdi_pubmed_primary_32781872

Language

English

Formats

Publication information

Publisher

More information

Scope and Contents

Contents

Alternative Titles

Full title

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_32781872

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_32781872

Other Identifiers

ISSN

E-ISSN

DOI

How to access this item